Molecular Diagnostics Technologies Market - Strategic Insights and Forecasts (2026-2031)

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

1. 2.1. Market Overview

2. 2.2. Market Definition

3. 2.3. Scope of the Study

4. 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

1. 3.1. Market Drivers

2. 3.2. Market Restraints

3. 3.3. Market Opportunities

4. 3.4. Porter’s Five Forces Analysis

5. 3.5. Industry Value Chain Analysis

6. 3.6. Policies and Regulations

7. 3.7. Strategic Recommendations

8. 3.8. Product Pipeline Analysis

9. 3.9. Incidence and Prevalence Analysis

10. 3.10. Patent Analysis

4. TECHNOLOGICAL OUTLOOK

5. MOLECULAR DIAGNOSTICS TECHNOLOGIES MARKET BY PRODUCT TYPE

1. 5.1. Introduction

2. 5.2. Instruments

3. 5.3. Reagents & Kits

4. 5.4. Software & Services

6. MOLECULAR DIAGNOSTICS TECHNOLOGIES MARKET BY TECHNOLOGY

1. 6.1. Introduction

2. 6.2. Polymerase Chain Reaction (PCR)

3. 6.3. Next-Generation Sequencing (NGS)

4. 6.4. In Situ Hybridization (ISH)

5. 6.5. Microarrays

6. 6.6. Isothermal Nucleic Acid Amplification

7. MOLECULAR DIAGNOSTICS TECHNOLOGIES MARKET BY APPLICATION

1. 7.1. Introduction

2. 7.2. Infectious Diseases

3. 7.3. Oncology

4. 7.4. Genetic Testing

5. 7.5. Blood Screening

6. 7.6. Transplant Diagnostics

8. MOLECULAR DIAGNOSTICS TECHNOLOGIES MARKET BY GEOGRAPHY

1. 8.1. Introduction

2. 8.2. North America

   1. 8.2.1. USA

   2. 8.2.2. Canada

   3. 8.2.3. Mexico

3. 8.3. South America

   1. 8.3.1. Brazil

   2. 8.3.2. Argentina

   3. 8.3.3. Others

4. 8.4. Europe

   1. 8.4.1. United Kingdom

   2. 8.4.2. Germany

   3. 8.4.3. France

   4. 8.4.4. Spain

   5. 8.4.5. Others

5. 8.5. Middle East and Africa

   1. 8.5.1. Saudi Arabia

   2. 8.5.2. UAE

   3. 8.5.3. Others

6. 8.6. Asia Pacific

   1. 8.6.1. China

   2. 8.6.2. India

   3. 8.6.3. Japan

   4. 8.6.4. South Korea

   5. 8.6.5. Indonesia

   6. 8.6.6. Thailand

   7. 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

1. 8.1. Major Players and Strategy Analysis

2. 8.2. Market Share Analysis

3. 8.3. Mergers, Acquisitions, Agreements, and Collaborations

4. 8.4. Competitive Dashboard

10. COMPANY PROFILES

1. 10.1. Roche Diagnostics

2. 10.2 Thermo Fisher Scientific

3. 10.3. Abbott Laboratories

4. 10.4. Danaher Corporation

5. 10.5. Qiagen

6. 10.6. Bio-Rad Laboratories

7. 10.7. Hologic

8. 10.8. Agilent Technologies

9. 10.9. Illumina

10. 10.10. Siemens Healthineers

11. APPENDIX

1. 11.1. Currency

2. 11.2. Assumptions

3. 11.3. Base and Forecast Years Timeline

4. 11.4. Key benefits for the stakeholders

5. 11.5. Research Methodology

6. 11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES